US Patent 8080393 Methods for production of oligonucleotides
Patent 8080393 was granted and assigned to Olink AB on December, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 3 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+448 characters)
Article
Patent abstract
The present invention relates to production of oligonucleotides using rolling circle replication, wherein synthesised multimeric oligonucleotides are reduced to mononucleotides using a nicking cassette. Thus, the invention provides a method for the production of oligonucleotides, enabling efficient amplification of oligonucleotides at lengths up to at least 1000 nucleotides and in high amounts contained within a nicking cassette.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08080393 Methods for production of oligonucleotides US Patent 8080393 Methods for production of oligonucleotides
Infobox
Patent Number
0808039300
Patent Number
808039300
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080803930
Date of Patent
December 20, 2011
0Patent Application Number
119115210
Date Filed
April 10, 2006
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080803930
Date of Patent
December 20, 2011
0Patent Application Number
119115210
Date Filed
April 10, 2006
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08080393 Methods for production of oligonucleotides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08080393
Date of patent
December 20, 2011
Patent application number
11911521
Date Filed
April 10, 2006
Patent primary examiner
Find more entities like US Patent 8080393 Methods for production of oligonucleotides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.